About Cyberonics
Cyberonics is a publicly listed company based in Houston (United States) founded in 1987. It operates as a vagus nerve stimulation therapy is developed for epilepsy and depression. The company has 660 employees. Cyberonics has completed 1 acquisition, including Sorin Group. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is CYBERONICS INC. Its competitors include NeuroPace, Cadence Neuroscience, Engage Therapeutics, CerboMed and NightWatch and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Cyberonics was founded in 1987 in Houston, United States, focusing on medical device development in the neuromodulation sector. A Vagus Nerve Stimulation Therapy system is produced and distributed, featuring an implanted device that sends electrical pulses to the vagus nerve. FDA approval has been granted for its use in managing refractory epilepsy and treatment-resistant depression, with operations centered in the U.S. healthcare market.
- Headquarters Houston, United States
- Employees 660
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website cyberonics.com
- Social LinkedIn X Facebook
- Legal Name Cyberonics Inc
- Employee Count660
- Investments & Acquisitions
Investments & Acquisitions by Cyberonics
Cyberonics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sorin Group.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical devices for cardiac surgery and rhythm management are developed. | sorin.com | Milan, Italy | 1956 | Feb 2015 | $1.4B |
Complete acquisition details for Cyberonics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cyberonics
3 dated milestones of Cyberonics across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Cyberonics is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Sorin Group.
Competitors of Cyberonics
Cyberonics has 8 listed competitors in our database, 5 of them funded. They include NeuroPace, Cadence Neuroscience, Engage Therapeutics, CerboMed and NightWatch, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neuropace.com | 1997 | United States | $263.56M | 184 | Implantable neurostimulation systems for epilepsy treatment are developed. | |
| cadenceneuro.com | 2016 | Redmond, United States | $41.03M | – | Medical devices for treating neurological disorders like epilepsy are developed. | |
| engagetherapeutics.com | 2017 | Summit, United States | $30.6M | – | Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures | |
| cerbomed.de | 2005 | Erlangen, Germany | $2.6M | – | Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders. | |
| nightwatchepilepsy.com | 2013 | Leiden, Netherlands | – | – | Wearable armbands for detecting epileptic seizures during sleep are offered. | |
| precisis.de | 2002 | Heidelberg, Germany | – | 14 | Devices and tools for neurological surgery are developed. | |
| neurolinkmedical.com | 2007 | San Antonio, United States | $3.88M | – | Develops drug-device combinations for epilepsy treatment. | |
| squalusmed.com | 2019 | Caesarea, Israel | – | – | Image-guided laser platforms are developed for epilepsy treatment. |
Detailed competitors of Cyberonics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cyberonics
Websites that share an audience with Cyberonics (cyberonics.com).
Websites whose visitors overlap most with Cyberonics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hmint.com | hmint.com | 100% | – | – | – |
| labrada.com | 100% | – | #2,266,268 | View details | |
villagecompounding.com | villagecompounding.com | 100% | – | #12,598,835 | – |
medical-supplies-equipment-company.com | medical-supplies-equipment-company.com | 100% | – | #3,258,117 | – |
cardiosoft.com | cardiosoft.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Cyberonics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Neurology
10 companies that operate in the same segment as Cyberonics (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cyberonics
Complete news archive for Cyberonics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyberonics
Cyberonics was founded in 1987.
Cyberonics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Cyberonics has 660 employees.
Cyberonics was founded in 1987 in Houston, United States, focusing on medical device development in the neuromodulation sector. A Vagus Nerve Stimulation Therapy system is produced and distributed, featuring an implanted device that sends electrical pulses to the vagus nerve. FDA approval has been granted for its use in managing refractory epilepsy and treatment-resistant depression, with operations centered in the U.S. healthcare market.
Cyberonics's top competitors include NeuroPace, Engage Therapeutics and Cadence Neuroscience.
Cyberonics has made 1 acquisition, including Sorin Group.
Cyberonics operates through Cyberonics Inc.